Clinical Research Directory
Browse clinical research sites, groups, and studies.
Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder
Sponsor: State University of New York - Upstate Medical University
Summary
This study will consist of a randomized, double-blind, sham-controlled clinical trial at SUNY Upstate Medical University and Mt. Sinai Medical Center with 80 autistic children evaluating the effects of transcranial photobiomodulation (tPBM) on multiple clinically validated scales.
Key Details
Gender
All
Age Range
2 Years - 8 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2023-10-17
Completion Date
2026-08-15
Last Updated
2025-10-14
Healthy Volunteers
No
Conditions
Interventions
Cognilum TM: Light Treatment Condition
The children will wear the CognilumTM device for approximately 10 minutes at a time, twice a week, for a period of 10 weeks.
Locations (2)
Mt. Sinai Medical Center
New York, New York, United States
Golisano Center for Special Needs
Syracuse, New York, United States